Zuclopenthixol dihydrochloride (Cis Z isomer) vs Zuclopenthixol (Cis Z/Trans E isomer)
Length of hospital stay · schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Findings
What do systematic reviews say?
90 questions · 91 findings · 2 reviews
No studies found 4 · 4.4%GRADE not reported 59 · 64.8%Very low 25 · 27.5%Low 3 · 3.3%Moderate 0 · 0%High 0 · 0%
Zuclopenthixol dihydrochloride (Cis Z isomer) vs Zuclopenthixol (Cis Z/Trans E isomer)
Mental state: Average endpoint general mental state score (clinically improved) (no data) · schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Zuclopenthixol dihydrochloride (Cis Z isomer) vs Zuclopenthixol (Cis Z/Trans E isomer)
Leaving the study early · schizophrenia
It is very uncertain whether zuclopenthixol dihydrochloride (Cis Z isomer) changes leaving the study early: Any reason compared with zuclopenthixol (Cis Z/Trans E isomer) (very low certainty).
1 finding from 1 review
- RR 2.15 [0.49, 9.41]4 studies · 140 participantsVery low
Zuclopenthixol dihydrochloride (Cis Z isomer) vs Zuclopenthixol (Cis Z/Trans E isomer)
General functioning: Average endpoint general functioning score (clinically improved) (no data) · schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Zuclopenthixol dihydrochloride vs placebo
Clinically significant response on global state · patients with schizophrenia
It is very uncertain whether ZUCLOPENTHIXOL DIHYDROCHLORIDE changes clinically significant response on global state ‐ as defined by each… compared with PLACEBO (very low certainty).
1 finding from 1 review
- RR 2.57 [1.06, 6.2]1 study · 29 participantsVery low
Zuclopenthixol dihydrochloride vs placebo
Relapse · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Zuclopenthixol dihydrochloride vs placebo
Clinically significant response on psychotic symptoms ‐ as defined by each of the studies. · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Zuclopenthixol dihydrochloride vs placebo
Adverse effects: 1. Sedation · patients with schizophrenia
It is very uncertain whether ZUCLOPENTHIXOL DIHYDROCHLORIDE changes adverse effects: Sedation compared with PLACEBO (very low certainty).
1 finding from 1 review
- RR 4.67 [1.23, 17.68]1 study · 29 participantsVery low
Zuclopenthixol dihydrochloride vs placebo
Average change in quality of life/satisfaction · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Zuclopenthixol dihydrochloride vs placebo
Quality of life/satisfaction with care for either recipients of care or carers: significant change in quality of life/satisfaction · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found